Sanofi India Plans to Sell Pharmaceutical Manufacturing Site in India to Zentiva

Date : 09/11/2019 @ 6:46AM
Source : Dow Jones News
Stock : Sanofi (SNY)
Quote : 46.04  -0.04 (-0.09%) @ 9:01PM

Sanofi India Plans to Sell Pharmaceutical Manufacturing Site in India to Zentiva

Sanofi (NASDAQ:SNY)
Historical Stock Chart

3 Months : From Sep 2019 to Dec 2019

Click Here for more Sanofi Charts.
   By P.R.Venkat 
 

Sanofi India Ltd. (500674.BY) said it is planning to sell a pharmaceutical manufacturing facility in the western Indian state of Gujarat to Zentiva.

Sanofi India, a unit of France-based Sanofi S.A. (SAN.FR), is selling the Ankleshwar site for 2.62 billion Indian rupees ($36.4 million), the company said in a statement on Wednesday.

The Ankleshwar site has a chemistry and biotechnology development centre, and manufactures both intermediates and pharmaceutical formulations. Sanofi's Ankleshwar site manufactures more than six billion tablets annually that include painkiller brands like Combiflam.

 

Write to venkat.pr@wsj.com

 

(END) Dow Jones Newswires

September 11, 2019 02:31 ET (06:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest SNY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.